NCT06732388 2026-04-13
Itraconazole in Combination With Ablation for the Prevention of Esophageal Cancer in Patients With High-risk Barrett's Esophagus
National Cancer Institute (NCI)
Phase 2 Not yet recruiting
Clinical Trials
11 trialsNCT05563766 2025-11-05
A Phase II Trial to Evaluate the Effect of Itraconazole on Pathologic Complete Response Rates in Resectable Esophageal Cancer
VA Office of Research and Development
Phase 2 Recruiting
NCT05048615 2023-01-25
Low-dose Venetoclax and Azacitidine as Front-line Therapy in Newly Diagnosed AML
Hospital Universitario Dr. Jose E. Gonzalez
Phase 2 Completed
NCT04018872 2021-11-04
Evaluating the Effect of Itraconazole on Pathologic Complete Response Rates in Esophageal Cancer
Dallas VA Medical Center
Phase 2 Recruiting
NCT04481100 2020-10-14
CCRT With Itraconazole in Locally Advanced Squamous Esophageal Cancer
Hangzhou Cancer Hospital
Phase 2 Unknown
NCT01787331 2020-02-05
Itraconazole in Treating Patients With Biochemically Relapsed Prostate Cancer
University of California, San Francisco
Phase 2 Completed
NCT00769600 2019-02-01
Phase II Study of Itraconazole and Pemetrexed in Patients With Previously Treated Non-Squamous NSCLC
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 2 Terminated
NCT01108094 2018-11-13
Pilot Biomarker Trial to Evaluate the Efficacy of Itraconazole in Patients w/ Basal Cell Carcinomas
Stanford University
Phase 2 Completed
NCT03664115 2018-09-10
Itraconazole in Non Small Cell Lung Cancer
Ain Shams University
Phase 2 Unknown
NCT00887458 2017-10-16
A Two-dose Level Clinical Trial of Itraconazole in Patients With Metastatic Prostate Cancer Who Have Had Disease Progression While on Hormonal Therapy
Johns Hopkins University
Phase 2 Completed
NCT01450683 2017-04-11
Study of Itraconazole in Castrate-resistant Prostate Cancer (CRPC) Post-chemotherapy
Stanford University
Phase 2 Terminated